1. Home
  2. RGNT vs PRSO Comparison

RGNT vs PRSO Comparison

Compare RGNT & PRSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Regentis Biomaterials Ltd. Ordinary Shares

RGNT

Regentis Biomaterials Ltd. Ordinary Shares

HOLD

Current Price

$2.02

Market Cap

13.6M

Sector

Health Care

ML Signal

HOLD

Logo Peraso Inc.

PRSO

Peraso Inc.

HOLD

Current Price

$0.63

Market Cap

13.4M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGNT
PRSO
Founded
2004
2008
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
13.6M
13.4M
IPO Year
2022
2000

Fundamental Metrics

Financial Performance
Metric
RGNT
PRSO
Price
$2.02
$0.63
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.00
AVG Volume (30 Days)
54.2K
256.0K
Earning Date
05-05-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
81.23
EPS
N/A
N/A
Revenue
N/A
$14,573,000.00
Revenue This Year
N/A
$18.48
Revenue Next Year
N/A
$53.57
P/E Ratio
N/A
N/A
Revenue Growth
N/A
5.99
52 Week Low
$1.23
$0.58
52 Week High
$15.50
$2.37

Technical Indicators

Market Signals
Indicator
RGNT
PRSO
Relative Strength Index (RSI) 47.93 40.02
Support Level $1.74 $0.60
Resistance Level $2.27 $0.92
Average True Range (ATR) 0.14 0.04
MACD 0.05 0.00
Stochastic Oscillator 44.78 23.01

Price Performance

Historical Comparison
RGNT
PRSO

About RGNT Regentis Biomaterials Ltd. Ordinary Shares

Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.

About PRSO Peraso Inc.

Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices, and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz to 300 GHz. Geographically, the company generates revenue from the United States, Hong Kong, Taiwan, Europe, and the Rest of the World.

Share on Social Networks: